Home  >  Foundations  >  Investors  >  Current reports  >  55/2022 Conclusion of an investment agreement regarding the acquisition of new shares in the Company for a contribution of approximately PLN 220 million (PLN 44.27 per share). Complete the review of strategic options. Disclosure of delayed confidential information - commencement of negotiations regarding the acquisition of 49.99% of the Company's share capital.
Logo Logo Logo Logo Logo
  • EN
  • PL
MENUMENU
  • About
        • About Us

        • Medicalgorithmics

          • In short
          • Executive Management
          • Our history
          • Partners
          • Newsroom
  • Products
        • Products

        • Arrhythmia
          diagnosis

          • Software
          • PocketECG
  • Investors
        • Investors

        • Foundations

          • Financal data
          • Current reports
          • Financial reports
        • Media

          • Presentations
          • Events calendar
          • Contact for Investors
        • Shares and bonds

          • Shareholders
          • Stock quotes
          • Dividend
          • Co-financed projects
          • Share issues
          • Bonds
        • Corporate governance

          • Supervisory board
          • Management
          • Best practices
          • Corporate documents
  • Contact
MENUMENU
  • About
        • About Us

        • Medicalgorithmics

          • In short
          • Executive Management
          • Our history
          • Partners
          • Newsroom
  • Products
        • Products

        • Arrhythmia
          diagnosis

          • Software
          • PocketECG
  • Investors
        • Investors

        • Foundations

          • Financal data
          • Current reports
          • Financial reports
        • Media

          • Presentations
          • Events calendar
          • Contact for Investors
        • Shares and bonds

          • Shareholders
          • Stock quotes
          • Dividend
          • Co-financed projects
          • Share issues
          • Bonds
        • Corporate governance

          • Supervisory board
          • Management
          • Best practices
          • Corporate documents
  • Contact
Home >  (Page 4)

01 Oct 55/2022 Conclusion of an investment agreement regarding the acquisition of new shares in the Company for a contribution of approximately PLN 220 million (PLN 44.27 per share). Complete the review of strategic options. Disclosure of delayed confidential information – commencement of negotiations regarding the acquisition of 49.99% of the Company’s share capital.

Posted at 22:30h in by Michał Zapora 0 Comments
0 Likes

...

Read More

28 Sep 54/2022 Q Patch technology registration delay – disclosure of delayed confidential information

Posted at 15:36h in by Sylwia Wójtowicz 0 Comments
0 Likes

...

Read More

28 Jul 52/2022 Conclusion of a final agreement to transfer 100% shares in Medi-Lynx Cardiac Monitoring LLC and conclusion of Support Agreement between React Health Holdings LLC and the Company

Posted at 23:42h in by Tomasz Kisiel 0 Comments
0 Likes

...

Read More

28 Jul 51/2022 System DRAI (DeepRhythmAI) registration by US Food and Drug Administration (FDA)

Posted at 23:21h in by Tomasz Kisiel 0 Comments
0 Likes

...

Read More

27 Jul 50/2022 List of shareholders holding at least 5 % of the total number of votes at the Extraordinary General Meeting of Medicalgorithmics S.A. on 27 July 2022.

Posted at 18:14h in by Monika Wnuk 0 Comments
0 Likes

...

Read More

27 Jul 49/2022 Resolutions of the Extraordinary General Meeting of Medicalgorithmics S.A. held on 27 July 2022

Posted at 18:06h in by Monika Wnuk 0 Comments
0 Likes

...

Read More

15 Jul 47/2022 Conclusion of a preliminary agreement for the sale of 100% of the membership interests in the Issuer’s subsidiary (Medi-Lynx Cardiac Monitoring, LLC)

Posted at 20:26h in by Paula Fijałkowska 0 Comments
0 Likes

...

Read More

05 Jul 46/2022 Appointment of Members of the Supervisory Board

Posted at 15:47h in by Paula Fijałkowska 0 Comments
0 Likes

...

Read More

01 Jul 45/2022 Correction of the current report 42/2022 regarding the list of shareholders holding at least 5% of votes in the total number of votes at the Ordinary General Meeting of Medicalgorithmics S.A. on June 30, 2022

Posted at 17:03h in by Paula Fijałkowska 0 Comments
0 Likes

...

Read More

01 Jul 45/2022 Korekta raportu bieżącego 42/2022 dotyczącego wykazu akcjonariuszy posiadających co najmniej 5 % głosów w ogólnej liczbie głosów na Zwyczajnym Walnym Zgromadzeniu Medicalgorithmics S.A. w dniu 30 czerwca 2022 r.

Posted at 15:50h in by Paula Fijałkowska 0 Comments
0 Likes

...

Read More
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • © copyright Medicalgorithmics.com 2018
  • Privacy policy
In shorts
  • Contact for Investors
  • Events calendar
  • Presentations
Products
  • Arrhythmia diagnosis
Contact
  • Contact us
  • Media pack
  • contact@medicalgorithmics.com
  • tel. + 48 22 825 12 49
  • PocketECG – Mobile Heart Monitor